| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.22 | 0.08 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.08 |